References
- Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020;70(1):7–30. doi:https://doi.org/10.3322/caac.21590
- Reid BM, Permuth JB, Sellers TA. Epidemiology of ovarian cancer: a review. Cancer Biol Med. 2017;14(1):9–32. doi:https://doi.org/10.20892/j.issn.2095-3941.2016.0084
- Deng Q, Geng Y, Zhao L, Li R, Zhang Z, Li K, Liang R, Shao X, Huang M, Zuo D, et al. NLRP3 inflammasomes in macrophages drive colorectal cancer metastasis to the liver. Cancer Lett. 2019;442:21–30. doi:https://doi.org/10.1016/j.canlet.2018.10.030
- Liu Y-S, Huang B-R, Lin C-J, Shen C-K, Lai S-W, Chen C-W, Lin H-J, Lin C-H, Hsieh Y-C, Lu D-Y, et al. Paliperidone inhibits glioblastoma growth in mouse brain tumor model and reduces PD-L1 expression. Cancers. 2021;13(17):4357. doi:https://doi.org/10.3390/cancers13174357
- Kim SH, Kim S-J, Park J, Joe Y, Lee SE, Saeidi S, Zhong X, Kim SH, Park S-A, Na H-K, et al. Reprograming of tumor-associated macrophages in breast tumor-bearing mice under chemotherapy by targeting heme oxygenase-1. Antioxidants (Basel). 2021;10(3):470. doi:https://doi.org/10.3390/antiox10030470
- Cavalcante RS, Ishikawa U, Silva ES, Silva-Júnior AA, Araújo AA, Cruz LJ, Chan AB, de Araújo Júnior RF. STAT3/NF-κB signalling disruption in M2 tumour-associated macrophages is a major target of PLGA nanocarriers/PD-L1 antibody immunomodulatory therapy in breast cancer. Br J Pharmacol. 2021;178(11):2284–304. doi:https://doi.org/10.1111/bph.15373
- Yagi T, Baba Y, Okadome K, Kiyozumi Y, Hiyoshi Y, Ishimoto T, Iwatsuki M, Miyamoto Y, Yoshida N, Watanabe M, et al. Tumour-associated macrophages are associated with poor prognosis and programmed death ligand 1 expression in oesophageal cancer. Eur J Cancer. 2019;111:38–49. doi:https://doi.org/10.1016/j.ejca.2019.01.018
- Tong L, Li J, Li Q, Wang X, Medikonda R, Zhao T, Li T, Ma H, Yi L, Liu P, et al. ACT001 reduces the expression of PD-L1 by inhibiting the phosphorylation of STAT3 in glioblastoma. Theranostics. 2020;10(13):5943–56. doi:https://doi.org/10.7150/thno.41498
- Vitale I, Manic G, Coussens LM, Kroemer G, Galluzzi L. Macrophages and metabolism in the tumor microenvironment. Cell Metab. 2019;30(1):36–50. doi:https://doi.org/10.1016/j.cmet.2019.06.001
- Krishnan V, Schaar B, Tallapragada S, Dorigo O. Tumor associated macrophages in gynecologic cancers. Gynecol Oncol. 2018;149(1):205–13. doi:https://doi.org/10.1016/j.ygyno.2018.01.014
- Hanel A, Carlberg C. Vitamin D and evolution: pharmacologic implications. Biochem Pharmacol. 2020;173:113595. doi:https://doi.org/10.1016/j.bcp.2019.07.024
- Holick MF. Vitamin D deficiency. N Engl J Med. 2007;357(3):266–81. doi:https://doi.org/10.1056/NEJMra070553
- Liu W, Zhang L, Xu H-J, Li Y, Hu C-M, Yang J-Y, Sun M-Y. The anti-inflammatory effects of vitamin D in tumorigenesis. IJMS. 2018;19(9):2736. doi:https://doi.org/10.3390/ijms19092736
- Deeb KK, Trump DL, Johnson CS. Vitamin D signalling pathways in cancer: potential for anticancer therapeutics. Nat Rev Cancer. 2007;7(9):684–700. doi:https://doi.org/10.1038/nrc2196
- Pawlik A, Anisiewicz A, Filip-Psurska B, Nowak M, Turlej E, Trynda J, Banach J, Gretkierewicz P, Wietrzyk J. Calcitriol and its analogs establish the immunosuppressive microenvironment that drives metastasis in 4T1 mouse mammary gland cancer. IJMS. 2018;19(7):2116. doi:https://doi.org/10.3390/ijms19072116
- Anisiewicz A, Łabędź N, Krauze I, Wietrzyk J. Calcitriol in the presence of conditioned media from metastatic breast cancer cells enhances ex vivo polarization of m2 alternative murine bone marrow-derived macrophages. Cancers. 2020;12(11):3485. doi:https://doi.org/10.3390/cancers12113485
- Zeng X-Y, Xie H, Yuan J, Jiang X-Y, Yong J-H, Zeng D, Dou Y-Y, Xiao S-S. M2-like tumor-associated macrophages-secreted EGF promotes epithelial ovarian cancer metastasis via activating EGFR-ERK signaling and suppressing lncRNA LIMT expression. Cancer Biol Ther. 2019;20(7):956–66. doi:https://doi.org/10.1080/15384047.2018.1564567
- Wang P, Xu J, You W, Hou Y, Wang S, Ma Y, Tan J, Zhang Z, Hu W, Li B. Knockdown of CYP24A1 aggravates 1α,25(OH)2D3-inhibited migration and invasion of mouse ovarian epithelial cells by suppressing EMT. Front Oncol. 2020;10:1258. doi:https://doi.org/10.3389/fonc.2020.01258
- Wang N, Wang Q, Chi J, Xiang F, Lin M, Wang W, Wei F, Feng Y. Carcinoembryonic antigen cell adhesion molecule 1 inhibits the antitumor effect of neutrophils in tongue squamous cell carcinoma. Cancer Sci. 2019;110(2):519–29. doi:https://doi.org/10.1111/cas.13909
- Wilson C, Qiu L, Hong Y, Karnik T, Tadros G, Mau B, Ma T, Mu Y, New J, Louie RJ, et al. The histone demethylase KDM4B regulates peritoneal seeding of ovarian cancer. Oncogene. 2017;36(18):2565–76. doi:https://doi.org/10.1038/onc.2016.412
- Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603–5. doi:https://doi.org/10.1007/s10654-010-9491-z
- Genin M, Clement F, Fattaccioli A, Raes M, Michiels C. M1 and M2 macrophages derived from THP-1 cells differentially modulate the response of cancer cells to etoposide. BMC Cancer. 2015;15:577. doi:https://doi.org/10.1186/s12885-015-1546-9
- Yin M, Li X, Tan S, Zhou HJ, Ji W, Bellone S, Xu X, Zhang H, Santin AD, Lou G, et al. Tumor-associated macrophages drive spheroid formation during early transcoelomic metastasis of ovarian cancer. J Clin Invest. 2016;126(11):4157–73. doi:https://doi.org/10.1172/JCI87252
- No JH, Moon JM, Kim K, Kim YB. Prognostic significance of serum soluble CD163 level in patients with epithelial ovarian cancer. Gynecol Obstet Invest. 2013;75(4):263–7. doi:https://doi.org/10.1159/000349892
- Lan C, Huang X, Lin S, Huang H, Cai Q, Wan T, Lu J, Liu J. Expression of M2-polarized macrophages is associated with poor prognosis for advanced epithelial ovarian cancer. Technol Cancer Res Treat. 2013;12(3):259–67. doi:https://doi.org/10.7785/tcrt.2012.500312
- Lan C, Huang X, Lin S, Huang H, Cai Q, Lu J, Liu J. High density of IL-17-producing cells is associated with improved prognosis for advanced epithelial ovarian cancer. Cell Tissue Res. 2013;352(2):351–9. doi:https://doi.org/10.1007/s00441-013-1567-0
- Le Page C, Marineau A, Bonza PK, Rahimi K, Cyr L, Labouba I, Madore J, Delvoye N, Mes-Masson A-M, Provencher DM, et al. BTN3A2 expression in epithelial ovarian cancer is associated with higher tumor infiltrating T cells and a better prognosis. PLoS One. 2012;7(6):e38541. doi:https://doi.org/10.1371/journal.pone.0038541
- Huang Fuhai PL, Chuyan XU. The correlation of tumor-associated macrophages with ovarian cancer tissue and its prognosis. China Medicine and Pharmacy. 2016;6:4.
- Wang Hong DK, Yuhua Z, Yuling WANG, Qiaosheng CAI. Relationship between ovarian cancer and tumor associated macrophages and its influence on prognosis. China Medicine and Pharmacy. 2016;6:3.
- Ting Wan JHL, Zheng LM, Cail MY, Ding T. Prognostic significance of tumor—associated macrophage infiltration in advanced epithelial ovarian carcinoma. Chinese Journal of Cancer. 2009;28:5.
- Noy R, Pollard JW. Tumor-associated macrophages: from mechanisms to therapy. Immunity. 2014;41(1):49–61. doi:https://doi.org/10.1016/j.immuni.2014.06.010
- Cassetta L, Pollard JW. Targeting macrophages: therapeutic approaches in cancer. Nat Rev Drug Discov. 2018;17(12):887–904. doi:https://doi.org/10.1038/nrd.2018.169
- Forssell J, Oberg A, Henriksson ML, Stenling R, Jung A, Palmqvist R. High macrophage infiltration along the tumor front correlates with improved survival in colon cancer. Clin Cancer Res. 2007;13(5):1472–9. doi:https://doi.org/10.1158/1078-0432.CCR-06-2073
- Reinartz S, Schumann T, Finkernagel F, Wortmann A, Jansen JM, Meissner W, Krause M, Schwörer A‐M, Wagner U, Müller‐Brüsselbach S, et al. Mixed-polarization phenotype of ascites-associated macrophages in human ovarian carcinoma: correlation of CD163 expression, cytokine levels and early relapse. Int J Cancer. 2014;134(1):32–42. doi:https://doi.org/10.1002/ijc.28335
- Zhang M, He Y, Sun X, Li Q, Wang W, Zhao A, Di W. A high M1/M2 ratio of tumor-associated macrophages is associated with extended survival in ovarian cancer patients. J Ovarian Res. 2014;7(1):16. doi:https://doi.org/10.1186/1757-2215-7-19
- Hensler M, Kasikova L, Fiser K, Rakova J, Skapa P, Laco J, Lanickova T, Pecen L, Truxova I, Vosahlikova S, et al. M2-like macrophages dictate clinically relevant immunosuppression in metastatic ovarian cancer. J Immunother Cancer. 2020;8(2):e000979. doi:https://doi.org/10.1136/jitc-2020-000979
- Yuan X, Zhang J, Li D, Mao Y, Mo F, Du W, Ma X. Prognostic significance of tumor-associated macrophages in ovarian cancer: a meta-analysis. Gynecol Oncol. 2017;147(1):181–7. doi:https://doi.org/10.1016/j.ygyno.2017.07.007
- Hagemann T, Wilson J, Kulbe H, Li NF, Leinster DA, Charles K, Klemm F, Pukrop T, Binder C, Balkwill FR, et al. Macrophages induce invasiveness of epithelial cancer cells via NF-kappa B and JNK. J Immunol. 2005;175(2):1197–205. doi:https://doi.org/10.4049/jimmunol.175.2.1197
- El-Arabey AA, Abdalla M, Abd-Allah AR. Ovarian cancer immunotherapy of NF-κB may have a dark side . Hum Cell. 2021;34(3):1019–20. doi:https://doi.org/10.1007/s13577-021-00490-7
- Hu Y, Li D, Wu A, Qiu X, Di W, Huang L, Qiu L. TWEAK-stimulated macrophages inhibit metastasis of epithelial ovarian cancer via exosomal shuttling of microRNA. Cancer Lett. 2017;393:60–7. doi:https://doi.org/10.1016/j.canlet.2017.02.009
- Carroll MJ, Fogg KC, Patel HA, Krause HB, Mancha A-S, Patankar MS, Weisman PS, Barroilhet L, Kreeger PK. Alternatively-activated macrophages upregulate mesothelial expression of P-selectin to enhance adhesion of ovarian cancer cells. Cancer Res. 2018;78(13):3560–73. doi:https://doi.org/10.1158/0008-5472.CAN-17-3341
- Liu Y, Metzinger MN, Lewellen KA, Cripps SN, Carey KD, Harper EI, Shi Z, Tarwater L, Grisoli A, Lee E, et al. Obesity contributes to ovarian cancer metastatic success through increased lipogenesis, enhanced vascularity, and decreased infiltration of M1 macrophages. Cancer Res. 2015;75(23):5046–57. doi:https://doi.org/10.1158/0008-5472.CAN-15-0706
- Vanherwegen AS, Gysemans C, Mathieu C. Vitamin D endocrinology on the cross-road between immunity and metabolism. Mol Cell Endocrinol. 2017;453:52–67. doi:https://doi.org/10.1016/j.mce.2017.04.018
- Das LM, Binko AM, Traylor ZP, Peng H, Lu KQ. Vitamin D improves sunburns by increasing autophagy in M2 macrophages. Autophagy. 2019;15(5):813–26. doi:https://doi.org/10.1080/15548627.2019.1569298
- Wasnik S, Rundle CH, Baylink DJ, Yazdi MS, Carreon EE, Xu Y, Qin X, Lau K-HW, Tang X. 1,25-Dihydroxyvitamin D suppresses M1 macrophages and promotes M2 differentiation at bone injury sites. JCI Insight. 2018;3(17):e98773. doi:https://doi.org/10.1172/jci.insight.98773
- Pollard JW. Tumour-educated macrophages promote tumour progression and metastasis. Nat Rev Cancer. 2004;4(1):71–8. doi:https://doi.org/10.1038/nrc1256
- Ghoneum A, Almousa S, Warren B, Abdulfattah AY, Shu J, Abouelfadl H, Gonzalez D, Livingston C, Said N. Exploring the clinical value of tumor microenvironment in platinum-resistant ovarian cancer. Semin Cancer Biol. 2021;77(12):83–98. doi:https://doi.org/10.1016/j.semcancer.2020.12.024
- David Milliken CS, Raju S, Fran Balkwill AJW. Analysis of chemokines and chemokine receptor expression in ovarian cancer ascites. Clin Cancer Res. 2002;8:6.
- Reinartz S, Finkernagel F, Adhikary T, Rohnalter V, Schumann T, Schober Y, Nockher WA, Nist A, Stiewe T, Jansen JM, et al. A transcriptome-based global map of signaling pathways in the ovarian cancer microenvironment associated with clinical outcome. Genome Biol. 2016;17(1):108. doi:https://doi.org/10.1186/s13059-016-0956-6
- Riester M, Wei W, Waldron L, Culhane AC, Trippa L, et al. Risk prediction for late-stage ovarian cancer by meta-analysis of 1525 patient samples. J Natl Cancer Inst. 2014;106:dju048.
- Vaughan S, Coward JI, Bast RC, Berchuck A, Berek JS, Brenton JD, Coukos G, Crum CC, Drapkin R, Etemadmoghadam D, et al. Rethinking ovarian cancer: recommendations for improving outcomes. Nat Rev Cancer. 2011;11(10):719–25. doi:https://doi.org/10.1038/nrc3144
- Worzfeld T, Pogge von Strandmann E, Huber M, Adhikary T, Wagner U, Reinartz S, Müller R. The unique molecular and cellular microenvironment of ovarian cancer. Front Oncol. 2017;7:24. doi:https://doi.org/10.3389/fonc.2017.00024
- El-Arabey AA, Denizli M, Kanlikilicer P, Bayraktar R, Ivan C, Rashed M, Kabil N, Ozpolat B, Calin GA, Salama SA, et al. GATA3 as a master regulator for interactions of tumor-associated macrophages with high-grade serous ovarian carcinoma. Cell Signal. 2020;68:109539. doi:https://doi.org/10.1016/j.cellsig.2020.109539
- El-Arabey AA, Abdalla M, Abd-Allah AR. GATA3 and stemness of high-grade serous ovarian carcinoma: novel hope for the deadliest type of ovarian cancer. Hum Cell. 2020;33(3):904–6. doi:https://doi.org/10.1007/s13577-020-00368-0
- El-Arabey AA, Abdalla M. GATA3 as a regulator for naughty cancer-associated fibroblasts in the microenvironment of high-grade serous ovarian cancer. Hum Cell. 2021;34(6):1934–6. doi:https://doi.org/10.1007/s13577-021-00598-w
- El-Arabey AA, Abdalla M, Abd-Allah AR. SnapShot: TP53 status and macrophages infiltration in TCGA-analyzed tumors. Int Immunopharmacol. 2020;86:106758. doi:https://doi.org/10.1016/j.intimp.2020.106758
- Grant DJ, Manichaikul A, Alberg AJ, Bandera EV, Barnholtz-Sloan J, Bondy M, Cote ML, Funkhouser E, Moorman PG, Peres LC, et al. Evaluation of vitamin D biosynthesis and pathway target genes reveals UGT2A1/2 and EGFR polymorphisms associated with epithelial ovarian cancer in African American women. Cancer Med. 2019;8(5):2503–13. doi:https://doi.org/10.1002/cam4.1996
- Kaler P, Augenlicht L, Klampfer L. Macrophage-derived IL-1beta stimulates Wnt signaling and growth of colon cancer cells: a crosstalk interrupted by vitamin D3. Oncogene. 2009;28(44):3892–902. doi:https://doi.org/10.1038/onc.2009.247
- Zhang Y, Guo Q, Zhang Z, Bai N, Liu Z, Xiong M, Wei Y, Xiang R, Tan X. VDR status arbitrates the prometastatic effects of tumor-associated macrophages. Mol Cancer Res. 2014;12(8):1181–91. doi:https://doi.org/10.1158/1541-7786.MCR-14-0036
- Hagemann T, Wilson J, Burke F, Kulbe H, Li NF, Plüddemann A, Charles K, Gordon S, Balkwill FR. Ovarian cancer cells polarize macrophages toward a tumor-associated phenotype. J Immunol. 2006;176(8):5023–32. doi:https://doi.org/10.4049/jimmunol.176.8.5023
- Zhao Y, Yu Z, Ma R, Zhang Y, Zhao L, Yan Y, Lv X, Zhang L, Su P, Bi J, et al. lncRNA-Xist/miR-101-3p/KLF6/C/EBPα axis promotes TAM polarization to regulate cancer cell proliferation and migration. Mol Ther Nucleic Acids. 2021;23:536–51. doi:https://doi.org/10.1016/j.omtn.2020.12.005
- Ko SY, Ladanyi A, Lengyel E, Naora H. Expression of the homeobox gene HOXA9 in ovarian cancer induces peritoneal macrophages to acquire an M2 tumor-promoting phenotype. Am J Pathol. 2014;184(1):271–81. doi:https://doi.org/10.1016/j.ajpath.2013.09.017